Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

7 Penny Stocks to Sell Before Year End

Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express (NYSE:EXPR) Meta Materials (NASDAQ:MMAT) Phunware (NASDAQ:PHUN) Progenity (NASDAQ:PROG) Lordstown Motors (NASDAQ:RIDE)

Vinco Ventures Stock Is Still as Confusing and Speculative as Ever

A few months back, BBIG stock was a great meme play. Down the road, it may be an interesting long-term bet on Lomotif. For now, it's best to hold off on it.

Worry About Valuation, Not Politics With the Silverbox Engaged/Black Rifle Deal

Political affiliation aside, it will be hitting its financial targets that will determine whether SBEA stock sinks or soars post-deSPACing.

Insider Selling Raises a Red Flag for Sofi Stock

While the "smart money" cashes in some of its chips, and inflation/interest worries rise again, take your time before buying SOFI stock.

Think Twice Before You Roll the Dice on Ocugen Stock

OCGN stock may spike once again on positive news, but investors' best best is to steer clear of it at this point in time.